Document is current
Any future updates will be listed below
-
Authors
Jutten, Roos J. https://orcid.org/0000-0002-3712-4790
Soberanes, Daniel https://orcid.org/0000-0001-9099-7294
Molinare, Cassidy P.
Hsieh, Stephanie
Farrell, Michelle E.
Schultz, Aaron S.
Rentz, Dorene M.
Marshall, Gad A.
Johnson, Keith A.
Sperling, Reisa A.
Amariglio, Rebecca E.
Papp, Kathryn V.
-
Funding
Funding for this research was provided by:
Alzheimer's Association (AARF-22-967786)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG067021, P01AG036694, P01AG036694, R01AG058825-01A)
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 15 November 2024
First Online: 13 January 2025
Competing interests
: G.A.M. has received research salary support for serving as site principal investigator for clinical trials funded by Eisai Inc., Eli Lilly and Company, and Genentech; this work is not related to the current study. R.A.S. has served as a consultant for Abbvie, AC Immune, Acumen, Alector, Biohaven, Bristol-Myers Squibb, Genentech/Roche, Ionis, Janssen, Merck, Oligomerix, Prothena, Vaxxinity. She has research funding, but no salary support or personal income for public-private partnership trials from Eisai and Co., and Eli Lilly and Co. This work is not related to the current study. All other authors declare no financial or non-financial competing interests.
